| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |